These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
25. A Phase II study of external-beam radiotherapy and endovascular brachytherapy with PTA and stenting for femoropopliteal artery restenosis. Narayan K; Denton M; Das R; Bernshaw D; Rolfo A; van Dyk S; Mirakian A Int J Radiat Oncol Biol Phys; 2006 Sep; 66(1):238-43. PubMed ID: 16820271 [TBL] [Abstract][Full Text] [Related]
26. A pharmacokinetic and safety study of a novel polymeric paclitaxel formulation for oral application. Veltkamp SA; Alderden-Los C; Sharma A; Rosing H; Beijnen JH; Schellens JH Cancer Chemother Pharmacol; 2007 Jan; 59(1):43-50. PubMed ID: 16680462 [TBL] [Abstract][Full Text] [Related]
27. Paclitaxel-Coated Balloons: Investigation of Drug Transfer in Healthy and Atherosclerotic Arteries - First Experimental Results in Rabbits at Low Inflation Pressure. Stolzenburg N; Breinl J; Bienek S; Jaguszewski M; Löchel M; Taupitz M; Speck U; Wagner S; Schnorr J Cardiovasc Drugs Ther; 2016 Jun; 30(3):263-70. PubMed ID: 27033233 [TBL] [Abstract][Full Text] [Related]
33. Paclitaxel-induced arterial wall toxicity and inflammation: tissue uptake in various dose densities in a minipig model. Radeleff B; Lopez-Benitez R; Stampfl U; Stampfl S; Sommer C; Thierjung H; Berger I; Kauffmann G; Richter GM J Vasc Interv Radiol; 2010 Aug; 21(8):1262-70. PubMed ID: 20656224 [TBL] [Abstract][Full Text] [Related]
34. Altered pharmacokinetics of paclitaxel by the concomitant use of morin in rats. Choi BC; Choi JS; Han HK Int J Pharm; 2006 Oct; 323(1-2):81-5. PubMed ID: 16806758 [TBL] [Abstract][Full Text] [Related]
35. New developments with drug-coated balloons. Tepe G J Cardiovasc Surg (Torino); 2016 Feb; 57(1):1-2. PubMed ID: 26771719 [No Abstract] [Full Text] [Related]
36. Balloon angioplasty of the femoro-popliteal segment: follow up results from southern India. Unni NM; Mandalam KR; Rao VR; Gupta AK; Joseph S; Rao AS; Unnikrishnan M; Neelakandhan KS Natl Med J India; 1995; 8(3):105-13. PubMed ID: 7780349 [TBL] [Abstract][Full Text] [Related]
37. Pharmacokinetics, biodistribution, efficacy and safety of N-octyl-O-sulfate chitosan micelles loaded with paclitaxel. Zhang C; Qu G; Sun Y; Wu X; Yao Z; Guo Q; Ding Q; Yuan S; Shen Z; Ping Q; Zhou H Biomaterials; 2008 Mar; 29(9):1233-41. PubMed ID: 18093646 [TBL] [Abstract][Full Text] [Related]
38. A phase I trial of intraperitoneal sustained-release paclitaxel microspheres (Paclimer) in recurrent ovarian cancer: a Gynecologic Oncology Group study. Armstrong DK; Fleming GF; Markman M; Bailey HH Gynecol Oncol; 2006 Nov; 103(2):391-6. PubMed ID: 16626792 [TBL] [Abstract][Full Text] [Related]
39. Drug-eluting stents for infrainguinal occlusive disease: progress and challenges. Tepe G Semin Vasc Surg; 2006 Jun; 19(2):102-8. PubMed ID: 16782516 [TBL] [Abstract][Full Text] [Related]
40. In-hospital costs of self-expanding nitinol stent implantation versus balloon angioplasty in the femoropopliteal artery (the VascuCoil Trial). Greenberg D; Rosenfield K; Garcia LA; Berezin RH; Lavelle T; Fogleman S; Cohen DJ J Vasc Interv Radiol; 2004 Oct; 15(10):1065-9. PubMed ID: 15466792 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]